Skip to main content
Top
Published in: Annals of Surgical Oncology 11/2023

27-06-2023 | Melanoma | Melanoma

The Role of Clinicopathologic Nomograms for Melanoma in the Era of Gene Expression Profiling

Authors: Raghav Tripathi, MD, MPH, Karen Larson, PhD, Graham Fowler, BA, John T. Vetto, MD, Jeremy S. Bordeaux, MD, MPH, Wesley Y. Yu, MD

Published in: Annals of Surgical Oncology | Issue 11/2023

Login to get access

Excerpt

Sentinel lymph node biopsy (SLNB) status is an important prognostic indicator for determining candidacy for adjuvant therapy in patients with melanoma, but is best utilized in patients with a high pretest probability of regional metastasis.1 Our study pooled data from the National Cancer Database (NCDB; 2004–2015) and the Surveillance, Epidemiology, and End Results [SEER] database (2000–2017) to develop and internally validate a nomogram to predict SLNB positivity in melanoma.2 This nomogram was externally validated using data from a large tertiary referral center, and the model was found to be comparable in accuracy to other published clinicopathologic nomograms.35
Literature
Metadata
Title
The Role of Clinicopathologic Nomograms for Melanoma in the Era of Gene Expression Profiling
Authors
Raghav Tripathi, MD, MPH
Karen Larson, PhD
Graham Fowler, BA
John T. Vetto, MD
Jeremy S. Bordeaux, MD, MPH
Wesley Y. Yu, MD
Publication date
27-06-2023
Publisher
Springer International Publishing
Keywords
Melanoma
Melanoma
Published in
Annals of Surgical Oncology / Issue 11/2023
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-023-13814-8

Other articles of this Issue 11/2023

Annals of Surgical Oncology 11/2023 Go to the issue